Login  
Research Report
 
 
Home >> Country >> HongKong/China >> Company
Latest Reports
Date Description Country Analyst Download
25-May-2022 CR Pharmaceutical (3320.HK) - Promote digital transformation and M&A cooperation to create competitive advantage through innovation and differentiation HongKong/China Margaret Li
26-Nov-2019 CR PHARMA (3320.HK) Develop Segments Cooperation, Improve Business Synergy HongKong/China Judy Li
02-Oct-2019 CR PHARMA (3320.HK) Distribution Business of 1H2019 Keeps Stable HongKong/China Judy Li
05-Aug-2019 CR PHARMA (3320.HK) China`s Leading Comprehensive Pharmaceutical Enterprise, Organic Growth and External Acquisition Boost Growth HongKong/China Judy Li
30-Jan-2019 CR Pharmaceutical (3320.HK) Acquiring New Drug Distribution Rights and Seeking to Enhance Competitiveness in Biopharmaceutical Field HongKong/China Margaret Li
06-Sep-2018 CR Pharmaceutical (3320.HK) Manufacturing business developed quickly and distribution segment consolidated leading position HongKong/China Margaret Li
29-Nov-2017 CR Pharmaceutical (3320.HK) Market Leader in Pharmaceutical Distribution and Manufacturing with Integration Synergies HongKong/China Margaret Li
Copyright © 2013. Brought to you by PhillipCapital (India) Pvt. Ltd.      Designed and developed by C-MOTS Infotech (ISO 9001:2015 certified)